Summary
Thermo Fisher Scientific Inc. (TMO) reported a modest revenue increase of 1% for the second quarter of 2003 compared to the prior year, reaching $516.4 million. This growth was primarily driven by favorable currency translation effects, which added $32.9 million, while underlying demand in certain segments, particularly Optical Technologies and Measurement and Control, saw a decrease. Profitability showed improvement, with operating income rising to $48.3 million from $35.2 million in the prior year's quarter. This was largely attributable to a significant reduction in restructuring and other costs, which fell from $16.1 million in Q2 2002 to $4.1 million in Q2 2003. The company also reported a gain on the sale of FLIR Systems, Inc. shares, contributing positively to 'Other Income, Net.' For the first six months of 2003, revenues were $1.017 billion, a 2% increase year-over-year, with operating income at $87.6 million, up from $71.9 million in the same period last year, also benefiting from lower restructuring expenses.
Key Highlights
- 1Revenue increased by 1% to $516.4 million for the second quarter of 2003, largely due to favorable currency translation effects.
- 2Operating income improved significantly to $48.3 million, up from $35.2 million in the prior year's quarter, driven by reduced restructuring costs.
- 3Restructuring and other costs decreased substantially from $16.1 million in Q2 2002 to $4.1 million in Q2 2003.
- 4The company reported gains from the sale of FLIR Systems, Inc. shares, contributing to 'Other Income, Net.'
- 5For the first six months of 2003, revenues grew 2% to $1.017 billion, with operating income up 22% to $87.6 million.
- 6The company redeemed $70.9 million in 4 3/8% subordinated convertible debentures in April 2003 and $197.1 million in 4% subordinated convertible debentures in July 2003 to reduce interest costs.